Quantifying Pediatric Neuro-oncology Risk Factors: Development of the Neurological Predictor Scale

Abstract

Pediatric neuro-oncology researchers face methodological challenges associated with quantifying the influence of tumor and treatment-related risk factors on child outcomes. The Neurological Predictor Scale was developed to serve as a cumulative index of a child's exposure to risk factors. The clinical utility of the Neurological Predictor Scale was explored in a sample of 25 children with heterogeneous brain tumors. Consistent with expectation, a series of regression analyses demonstrated that the Neurological Predictor Scale significantly predicted composite intellectual functioning (r ² = 0.21, p < .05), short-term memory (r ² = 0.16, p = .05), and abstract visual reasoning abilities (r ² = 0.28, p < .05). With the exception of chemotherapy, the Neurological Predictor Scale accounted for a significant amount of the variance in child intellectual functioning above and beyond individually examined variables. The Neurological Predictor Scale can be used to quickly quantify the cumulative risk factors associated with pediatric brain tumor diagnoses.

Keywords

brain tumor intelligence outcome research neuro-oncology

Get full access to this article

View all access options for this article.

References

Ater JL , Moore BD , Francis DJ , Castillo R. , et al. Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: utilization of a Neurological Severity Score. J Child Neurol. 1996;11:462-469.

Ris MD , Noll, RB Long-term neurobehavioral outcomes in pediatric brain tumor patients: review and methodological critique. J Clin Exp Neuropsychol. 1994;16:21-42.

Butler RW , Mulhern RK Neurocognitive interventions for children and adolescents surviving cancer . J Pediatr Psychol. 2005; 30:65-78.

Mulhern RK , Merchant TE , Gajjar A. , Reddick WE , et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5:399-408.

Ris MD Lessons in pediatric neuropsycho-oncology: what we have learned since Johnny Gunther. J Pediatric Psychol. 2007 [serial online] Available at: http://jpepsy.oxfordjournals.org/cgi/content/full/jsm018v1. Advance access: April 9, 2007.

Steinlen M. , Imfeld S. , Zulauf P. , Boltshauser E. , et al. Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood. Brain. 2003;126:1998-2008.

Butler RW , Haser JK Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev. 2006;12: 184-91.

Thorndike R. , Hagen E. , Sattler J. The Stanford-Binet Intelligence Scale: Technical Manual. 4th ed. Chicago, IL: Riverside Publishing Company; 1986.

Lezak MD , Howieson, DB , Loring, DW , Hannay, HJ , et al. Neuropsychological Assessment. 4th ed. New York, NY: Oxford University Press; 2004.

10.

Werba BE , Hobbie W. , Kazak AE , Ittenbach RF , Reilly AF , Meadows AT Classifying the intensity of pediatric cancer treatment protocols: the Intensity of Treatment Rating Scale 2.0 (ITR-2). Pediatr Blood Cancer .15;48:673-677.

11.

King TZ , Papazoglou A. , Morris RD , Krawiecki N. Attention Problems in Survivors of Pediatric Brain Tumors Predict Adult Adaptive Outcomes. Presented at: The Fifth Annual Meeting of the American Academy of Clinical Neuropsychology, Denver, Colorado, Jun 7-9, 2007.

12.

Papazoglou A. , King TZ , Partridge J. , Morris RD , Krawiecki N. Behavior Problems as Predictors of Later Adaptive Functioning in Children With Brain Tumors. Presented at: The Thirty-fifth Annual Meeting of the International Neuropsychological Society, Portland, Oregon, Feb 7-10, 2007.

13.

Butler RW , Copeland DR Attentional processes and their remediation in children treated for cancer: A literature review and the development of a therapeutic approach. J Int Neuropsychol Soc. 2002;8:115-124.